Newsletter Archive

1. 03.28.23 -- Trends In FDA FY2022 Inspection-based Warning Letters 3/28/2023
   03/28/23 Laboratory Network Newsletter
2. 03.14.23 -- Considerations For Microbial Enumeration Methods When Working With CDMOs 3/14/2023
   03/14/23 Laboratory Network Newsletter
3. 02.28.23 -- FDA Adopts ICH Final Guidance On Bioanalytical Method Validation 2/28/2023
   02/28/23 Laboratory Network Newsletter
4. 02.14.23 -- Considerations For Sterility Test Methods When Working With CDMOs 2/14/2023
   02/14/23 Laboratory Network Newsletter
5. 01.24.23 -- FDA Seeks Comment On Circumstances For Delaying, Denying, Limiting, Or Refusing An Inspection 1/24/2023
   01/24/23 Laboratory Network Newsletter
6. 01.10.23 -- ICH Issues Draft Guideline On Viral Safety Evaluation Of Biotech Products 1/10/2023
   01/10/23 Laboratory Network Newsletter
7. 12.20.22 -- How Can Nanomedicine Innovations Combat Cancer? 12/20/2022
   12/20/22 Laboratory Network Newsletter
8. 12.06.22 -- Digital Twins & The CGT Value Chain: A Universe Of Possibilities 12/6/2022
   12/06/22 Laboratory Network Newsletter
9. 11.22.22 -- Pharma 4.0 Software Methodologies In Biopharma & Medical Devices 11/22/2022
   11/22/22 Laboratory Network Newsletter
10. 11.08.22 -- 6 Drug Discovery Learnings From The Lab 11/8/2022
    11/08/22 Laboratory Network Newsletter